US Stock MarketDetailed Quotes
EFTRW EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM)
- 0.0281
- 0.00000.00%
Close May 1 16:00 ET
0Market Cap0.00P/E (TTM)
0.0000High0.0000Low0Volume0.0281Open0.0281Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.212552wk High0.00P/B0Float Cap0.018752wk Low--Dividend TTM0Shs Float2.4900Historical High--Div YieldTTM0.00%Amplitude0.0187Historical Low--Avg Price1Lot Size
EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM) Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -14.10%-29.55M | 17.91%-5.57M | 5.24%-7.76M | -93.60%-8.59M | -17.55%-7.64M | -4.06%-25.9M | -35.38%-6.78M | 9.74%-8.18M | 23.69%-4.44M | -30.02%-6.5M |
| Net income from continuing operations | -58.00%-35.81M | 1.40%-9.13M | 13.14%-8.3M | -20.95%-8.36M | -426.30%-10.01M | -243.47%-22.67M | -148.61%-9.26M | -207.66%-9.56M | -24.64%-6.92M | 146.63%3.07M |
| Operating gains losses | 99.53%-3K | ---- | ---- | ---- | ---- | -18.18%-637K | --0 | 86.51%-39K | -666.67%-153K | -182.26%-445K |
| Depreciation and amortization | 109.43%111K | 11.11%30K | 44.44%26K | 800.00%27K | 460.00%28K | 120.83%53K | 440.00%27K | 200.00%18K | -50.00%3K | -28.57%5K |
| Other non cash items | 103.26%346K | 13.16%86K | 1,050.00%76K | 108.02%93K | 100.95%91K | 78.14%-10.62M | 100.24%76K | 99.95%-8K | -1,373.63%-1.16M | -26,580.56%-9.53M |
| Change In working capital | -37.06%1.69M | 115.63%2.43M | -269.50%-521K | -157.93%-1.43M | 255.13%1.21M | 1,224.79%2.68M | -39.27%1.13M | 94.01%-141K | 547.02%2.47M | -195.94%-780K |
| -Change in prepaid assets | -62.73%587K | -78.51%185K | 72.38%-364K | -32.19%946K | -128.26%-180K | 224.02%1.58M | -12.05%861K | 28.76%-1.32M | 249.84%1.4M | 19.74%637K |
| -Change in payables and accrued expense | 0.11%907K | 926.64%2.2M | -118.03%-203K | -335.53%-2.43M | 191.46%1.34M | -53.44%906K | -74.12%214K | 149.12%1.13M | 169.63%1.03M | -613.68%-1.46M |
| -Change in other current assets | 0.00%192K | 0.00%48K | 0.00%48K | 0.00%48K | 0.00%48K | 121.26%192K | 2.13%48K | 105.05%48K | --48K | --48K |
| -Change in other working capital | -125.00%-1K | -166.67%-2K | -166.67%-2K | --0 | 400.00%3K | 136.36%4K | 200.00%3K | 175.00%3K | 75.00%-1K | 75.00%-1K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -14.10%-29.55M | 17.91%-5.57M | 5.24%-7.76M | -93.60%-8.59M | -17.55%-7.64M | -4.06%-25.9M | -35.38%-6.78M | 9.74%-8.18M | 23.69%-4.44M | -30.02%-6.5M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 181.10%14.48M | 146.99%8.95M | -152.86%-1.92M | -149.67%-1.57M | 131.93%9.03M | -3,261.06%-17.86M | 10,161.11%3.62M | 60,483.33%3.62M | 3.17M | -4,757.99%-28.27M |
| Net PPE purchase and sale | 49.48%-97K | -315.38%-54K | 95.56%-2K | 63.64%-28K | 77.19%-13K | -133.98%-192K | 63.89%-13K | -650.00%-45K | ---77K | -109.39%-57K |
| Net investment purchase and sale | 182.53%14.58M | 147.59%9M | -152.15%-1.91M | -147.63%-1.55M | 132.04%9.04M | ---17.67M | --3.64M | --3.67M | --3.25M | ---28.22M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 181.10%14.48M | 146.99%8.95M | -152.86%-1.92M | -149.67%-1.57M | 131.93%9.03M | -3,261.06%-17.86M | 10,161.11%3.62M | 60,483.33%3.62M | --3.17M | -4,757.99%-28.27M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 667.92%21.23M | 16,610.81%6.11M | 208.11%342K | 34,790.48%14.57M | -92.24%212K | -95.30%2.77M | -68.18%-37K | -99.79%111K | 46.15%-42K | -54.05%2.73M |
| Net common stock issuance | 656.59%21.18M | 16,610.81%6.11M | 191.89%324K | 34,700.00%14.53M | -92.34%212K | --2.8M | ---37K | 793.75%111K | -362.50%-42K | --2.77M |
| Proceeds from stock option exercised by employees | 1,766.67%56K | --0 | --18K | --38K | --0 | -94.64%3K | --0 | --0 | --0 | --3K |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | -100.07%-37K | --0 | --0 | --0 | -3,600.00%-37K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 667.92%21.23M | 16,610.81%6.11M | 208.11%342K | 34,790.48%14.57M | -92.24%212K | -95.30%2.77M | -68.18%-37K | -99.79%111K | 46.15%-42K | -54.05%2.73M |
| Net cash flow | ||||||||||
| Beginning cash position | -82.48%8.71M | -54.75%5.39M | -10.02%14.71M | -41.63%10.31M | -82.48%8.71M | 226.64%49.7M | -78.27%11.9M | 50.30%16.35M | 5.31%17.66M | 226.64%49.7M |
| Current changes in cash | 115.04%6.17M | 397.00%9.49M | -109.62%-9.33M | 435.93%4.4M | 105.00%1.6M | -218.87%-40.99M | 36.93%-3.2M | -110.14%-4.45M | 77.76%-1.31M | -2,156.35%-32.04M |
| End cash Position | 70.82%14.88M | 70.82%14.88M | -54.75%5.39M | -10.02%14.71M | -41.63%10.31M | -82.48%8.71M | -82.48%8.71M | -78.27%11.9M | 50.30%16.35M | 5.31%17.66M |
| Free cash flow | -13.63%-29.65M | 17.27%-5.62M | 5.74%-7.76M | -90.92%-8.62M | -16.72%-7.65M | -4.66%-26.09M | -34.67%-6.79M | 9.30%-8.23M | 22.37%-4.52M | -31.16%-6.55M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg